A new study co-led by investigators at UCLA has found a drug can reduce the risk of re-acquiring lung cancer, it was announced Sunday. Researchers at UCLA’s Health Jonsson Comprehensive Cancer Center discovered that cancer drug selpercatinib “can significantly reduce the risk of lung cancer returning in patients with a rare genetic subtype of early-stage […]
